Rapamycin inhibits the mammalian target of rapamycin (mTOR) (associated with the regulation of cell growth, proliferation, and immune responses) and is therefore an excellent therapeutic compound for the treatment of GBM. The gene discussed is MTOR; the disease is glioblastoma.